News Briefs

Walgreens Boots Alliance Inc. will spend $970 million to acquire a 71% stake in Shields Health Solutions, a specialty pharmacy company. Shields contracts with health systems and hospitals to build and operate on-site specialty pharmacies. The transaction builds on a minority investment that Walgreens made in July 2019. According to a Sept. 21 press release, Shields “represent[s] more than 1 million specialty patients across more than 30 disease states, with more than 70 health system partners nationwide.”

Inovalon Holdings Inc. struck a deal with CorEvitas LLC to gain access to CorEvitas’ analytics on rheumatoid arthritis and psoriasis. Inovalon will combine the data from the CorEvitas platform with its larger chronic condition database. According to a Sept. 21 press release on the deal, “insights made possible through these analytics can advance clinical development, inform trial design and recruitment, substantiate value narratives, and inform patient-specific intervention plans.”

© 2021 MMIT

AIS Health Staff

Related Posts

https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-Merck-COVID-19-Drug-Could-Gain-Emergency-Use-Authorization.jpg
October 14

Merck COVID-19 Drug Could Gain Emergency Use Authorization

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-More-MA-PD-PDP-Members-Will-Be-in-4-Star-Plans-in-2022.jpg
October 14

More MA-PD, PDP Members Will Be in 4-Star Plans in 2022

READ MORE
https://www.mmitnetwork.com/wp-content/uploads/2021/10/WordPress-Featured-Image-radar-on-drug-benefits-PhRMA-Blasts-Poll-About-Govt-Drug-Price-Negotiation-Support.jpg
October 14

PhRMA Blasts Poll About Gov’t Drug Price Negotiation Support

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today